ASR Vermogensbeheer N.V.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1916757 UTRECHT, P7

Position in NBIX

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$554,625

-$31,842 QoQ

Shares Held

4,210

+1.8% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

5 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ASR Vermogensbeheer N.V. holds $35,839,700 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	1,243,255	$29,751,092
2	ZTS	Zoetis Inc.	31,870	$3,767,352
3	TEVA	Teva Pharmaceutical Industries Ltd	34,615	$1,042,603
4	UTHR	UNITED THERAPEUTICS Corp	1,221	$724,028
5	NBIX	Neurocrine Biosciences Inc This page	4,210	$554,625

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$554,625	4,210	+1.8%	Shares	Defined	2026-04-30
2025-12-31	$586,467	4,135	-0.9%	Shares	Defined	2026-02-03
2025-09-30	$585,665	4,172	-0.5%	Shares	Defined	2025-10-28
2025-06-30	$526,892	4,192	-0.4%	Shares	Defined	2025-07-21
2025-03-31	$465,404	4,208	—	Shares	Defined	2025-05-09
No filing history on record for this holder in this stock.